Skip to main content

Acetaminophen updates

Recently, the FDA approved an IV formulation of acetaminophen (OFIRMEV) for the management of postoperative pain.
The argument for the IV route was to avoid the slow onset of the analgesic effects after oral delivery.

Since the introduction of the injectable formulation, there have been a large number of robust clinical trials on the efficacy of IV acetaminophen (Jones, 2011). Meta-analyses provide a strong indication of the efficacy of the IV formulation in single-dose, randomized, controlled clinical trials, for acute postoperative pain in adults or children.

In one series, 37% of patients receiving i.v. acetaminophen experienced at least 50% pain relief over 4 h compared with 16% (68/527) receiving placebo, with larger effects when baseline pain was greater; fewer patients receiving acetaminophen required rescue medications than those receiving placebo (McNicol et al., 2011). Other analyses demonstrate a significant reduction in postoperative morphine consumption in patients receiving IV acetaminophen (Maund et al., 2011). The analgesic effects of IV acetaminophen display a plateau at doses well above those recommended in the US (e.g., 5 mg/kg; Hahn et al., 2003).

 The recommended dose of OFIRMEV in adults is 1000 mg every 6 hrs, delivered as a 15 min infusion.
The maximum dose is 4000 mg in 24 hrs.
Contraindications are the same as those of oral acetaminophen formulations and include conditions of hepatic impairment or active hepatic disease, alcoholism, chronic malnutrition, severe hypovolemia, or severe renal impairment.

 MECHANISMS OF ACTION

 In fact acetaminophen displayed only modest anti-inflammatory effects.
Some  studies have demonstrated measurable but marginal inhibitory effects of acetaminophen on the COX1, 2, and 3 isoforms (Ouelle and Percival, 2001; Graham and Scott, 2005) suggesting that acetaminophen might act on central pain processing initiated by peripheral tissue injury and inflammation.

 Acetaminophen is deacetylated to p-aminophenol in the liver.
In the brain and spinal chord, p-aminophenol can be conjugated with arachidonic acid by fatty acid amide hydrolase (FAAH) to form N-arachidonoylphenolamine (AM404; Högestätt et al., 2005).
This particular product is an agonist at both TRPV1 (vanilloid or capsaicin) and CB1 (cannabinoid receptors), both of which are expressed heavily in neurons of the spinal and supraspinal pain pathways. While agonists of TRPV1 are thought to activate small primary afferent and produce pain, CB1 agonists are known to reduce nociceptive processing. Indeed, the effects of acetaminophen were reduced by CB1 antagonists (Ottani, et al., 2006).

 We conclude that the mechanism of action of acetaminophen has yet to be fully elucidated
Labels:

Comments

Post a Comment

Popular posts from this blog

power injectable peripherally inserted central catheters

Clinical experience with power injectable peripherally inserted central catheters in intensive care patients     Introduction In intensive care units (ICU), peripherally inserted central catheters (PICC) may be an alternative option to standard central venous catheters, particularly in patients with coagulation disorders or at high risk for infection. Some limits of PICCs (such as low flow rates) may be overcome by the use of power-injectable catheters . Method We have retrospectively reviewed all the power injectable PICCs inserted in adult and pediatric patients in the ICU during a 12-month period, focusing on the rate of complications at insertion and during maintenance. Results We have collected 89 power injectable PICCs (in adults and in children), both multiple and single lumen. All insertions were successful. There were no major complications at insertion and no episodes of catheter-related blood stream infection. Non-infective complications ...
1 comment
Read more

Falling from Height...The Prognostic factors

Falls from Height is Knwon to cause major morbidities and mortalities.  There are several prognostic factors for survival that have been identified: Height Age Type of surface Body part that touches the ground first Two other factors are important, but do not have a significant effect on mortality: Circumstances of the fall (suicide, accident, escape) Initial impact with an object before impacting the ground Height . Overall, about half of victims die at the scene, and a total of 70% die before they reach the hospital . The median height leading to death is about 49 feet, or about 4 to 5 storeys. 100% of victims die after falling 85 feet, or about 8 storeys. Age . Mortality increases with age due to pre-existing medical conditions and decreased physiologic reserve. Type of surface . The type of surface struck (i.e. grass, water, construction debris) can also have an effect on secondary injuries and survival. Mortality after striking a hard surface is nearly doubl...
Post a Comment
Read more

The 12 decision making steps for post dural puncture headache treatment

Treatment decision-making algorithm for postdural puncture headache. 1. When diagnosis is made, all patients should receive supportive measures (reassurance, bed rest, analgesics, hydration, quiet environment). 2. Severity of symptoms should be classified using VAS scale (mild 1–3, moderate 4–6, severe 7–10). 3. Virtually all patients will improve in time even without additional therapy. (dashed lines) 4. Symptoms worsen or fail to resolve within 5 days. 5. Patient preference dictates the choice between pharmacologic (less effective) and epidural blood patch (EBP). 6. In patients with severe symptoms, EBP is strongly suggested. 7. The most common pharmacologic measure is  caffeine  prescription. 8. The failure, worsening, or recurrence of symptoms after pharmacologic measures favors the use of EBP. 9. In addition to EBP, other epidural treatment options can be considered in select patients (eg,  dextran , saline). 10. A period of 24 h should lapse before repeating EBP. 11...
1 comment
Read more